Pharmacelera: Funding, Investors & Team (Sep 2026)
Pharmacelera is a company that applies accurate Quantum-Mechanics (QM) algorithms, Machine Learning (ML) and High-Performance Computing (HPC) to mine an unexploited chemical space and propose molecular candidates that have higher chances to become a drug. The patented computational technology derives from more than 25 years of research at the University of Barcelona and it has been validated in scientific peer-reviewed publications and benchmarking studies performed by our users and customers.
Pharmacelera has raised $7.1M across 1 funding round on record, the most recent an undisclosed round of $7.1M announced in Feb 2026.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Pharmacelera Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Pharmacelera Funding Rounds
Pharmacelera Founders and Leadership Team
Contact details for the Pharmacelera team: 1 of 1 has an email address on file.
Start 14-day free trial →Pharmacelera Funding Compared to Other Artificial Intelligence Startups
Pharmacelera's latest round of $7.1M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pharmacelera in Artificial Intelligence and Barcelona
Companies Similar to Pharmacelera
Openchip designs RISC-V-based SoCs and AI accelerators for HPC, AI, ML, and deep learning applications.
Substrate AI offers artificial intelligence technology for fintech, agriculture, energy, human resource, and…
SegurosIA is an insurtech focused on helping people and teams working in the insurance industry through…
Sincrolab is a company focused on creating and selling technological tools for neuropsychological…
NeuralTrust provides a platform for securing and governing AI agents used in enterprise environments. Its…
TrebezIA offers robotic solutions using AI technology to automate transportation and operational tasks.
Node.ai is the AI platform designed by and for investment professionals. Illiquid assets, traditional…
Optiak is an AI-based platform that develops a modular operating system designed to streamline operations.
Clinicgram is a digital health modular platform that uses digital imaging and artificial intelligence to…
Website: https://didit.me/ Whitepaper: https://whitepaper.didit.me/ Technical docs: https://docs.didit.me/…
Mathew is an educational platform that provides AI-powered software for teachers and students.
Pharmacelera Funding FAQs
What does Pharmacelera do?
Pharmacelera is a company that applies accurate Quantum-Mechanics (QM) algorithms, Machine Learning (ML) and High-Performance Computing (HPC) to mine an unexploited chemical space and propose molecular candidates that have higher chances to become a drug. The patented computational technology derives from more than 25 years of research at the University of Barcelona and it has been validated in scientific peer-reviewed publications and benchmarking studies performed by our users and customers.
How much funding has Pharmacelera raised?
Pharmacelera has raised $7.1M across 1 round on record. The most recent is an undisclosed round of $7.1M announced in Feb 2026.
When did Pharmacelera last raise funding?
Pharmacelera's most recent funding round on record is an undisclosed round of $7.1M, announced in Feb 2026.
Who founded Pharmacelera?
FundedIQ lists Enric Gibert (Founder) at Pharmacelera.
Where is Pharmacelera headquartered?
Pharmacelera is based in Barcelona, Catalonia, Spain.
How many employees does Pharmacelera have?
Pharmacelera is in the 11-50 employee band.
How does Pharmacelera's funding compare to other Artificial Intelligence startups?
Pharmacelera's latest round of $7.1M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Pharmacelera Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pharmacelera is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.